CHEE 440 1 DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals.

Slides:

Advertisements

Similar presentations

The Drug Discovery Process

Advertisements

Regulatory Framework Leigh Shaw, Director.

Single-Patient Use of Investigational Drugs and Biologic Products for Treating Cancer Grant Williams, M.D. Medical Team Leader DODP/CDER/FDA.

Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.

Clinical Trials Medical Interventions

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.

FEDERAL REGULATIONS OF MEDICATIONS Food, Drug and Cosmetic Act Protect consumers from adulterated and misbranded foods, drugs, cosmetics, or devices.

Special Topics in IND Regulation

Pharmaceutical Development and Review Process Rev. 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.

Stefan Franzén Introduction to clinical trials.

+ Drug Development and Review Process. + Objectives Learn the processes involved in drug discovery and development Define the phases involved in FDA drug.

U of Arizona Innovation Conference 20 September 2011 Marlene E. Haffner, MD, MPH Haffner Associates, LLC.

Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.

Biomedical research methods. What are biomedical research methods? An integrated approach using chemical, mathematical and computer simulations, in vitro.

Investigational New Drug Application 21 CFR Part 312 A Review for OCRA US RAC Study Group September 2005 Ginger Clasby, MS Promedica International

INVESTIGATIONAL DRUG SERVICES IN THE HOSPITAL Sheree Miller, Pharm.D. University of Washington Medical Center

REGISTRATION OF MEDICINES & PROGRESS WITH RESTRUCTURING THE MCC 1.

Stages of drug development

Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.

Yesterday, today, and tomorrow

Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.

Clinical Trials — A Closer Look. The Food and Drug Administration (FDA) is the main consumer watchdog for numerous products: Drugs and biologics (prescription.

Clinical Trials Amir Zarrinhaghighi

Stefan Franzén Introduction to clinical trials.

A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication A substance used in the diagnosis, treatment,

Investigational New Drug Application (IND)

When do I need an IND ? FDA Guidance for Industry – Investigation New Drug Applications (INDs) - Determining Whether Human Research Studies Can Be Conducted.

DRUG DEVELOPMENT & REGULATIONS DR ARIF HASHMI. DRUG DEVELOPMENT Discovery and synthesis Preclinical development (chemical testing, biological testing,

From the Lab to Market Unit 3.04 Understanding Biotechnology research & Development.

Nonclinical Perspective on Initiating Phase 1 Studies for Small Molecular Weight Compounds John K. Leighton, PH.D., DABT Supervisory Pharmacologist Division.

Biomedical Research Objective 2 Biomedical Research Methods.

Investigational Drugs in the hospital. + What is Investigational Drug? Investigational or experimental drugs are new drugs that have not yet been approved.

 1. A care plan is developed for each of the patient's medical conditions being managed with pharmacotherapy.  2. A goal of therapy is the desired response.

Drug - Device Combination Issues : Oncology Perspective Ramzi Dagher, M.D. DODP/CDER/FDA.

CLINICAL TRIALS IN NEW DRUG DEVELOPMENT Michael A Ross,M.D. President CPL Inc.

1/33.  What is INDA ?  Types of INDAs  Objectives of INDAs  Format & Contents of an INDA  IND Safety reports  IND Annual Reports  IND Review Process.

The New Drug Development Process (www. fda. gov/cder/handbook/develop

The FDA: Basic Facts It takes 12 to 15 years to develop a single drug Only 1 in 10,000 potential medications makes it completely through the process Only.

CHEE 4401 Definitions drug - any substance that affects the structure or functioning of an organism pharmaceutics - the area of study concerned with the.

FDA Office of Orphan Products Development

Focus on Nursing Pharmacology

C LINICAL R ESEARCH. CONTENTS Drug Development Process Pre – Clinical Studies Clinical Trials Phase I Phase II Phase III Phase IV 2.

“Journey of a Drug” From Test Tube TO Prescribing Physician.

European Patients’ Academy on Therapeutic Innovation The key principles of pharmacology.

Drug Regulation, Development, Names, and Information Chapter 3 Copyright (c) 2004 Elsevier Inc. All rights reserved.

OVER THE COUNTER MEDS INTRODUCTION No prescriptions are necessary and no questions need to be answered to attain these drugs OTC med use saves.

1 IND Applications for Academic Clinical Investigations John Marler, MD US Food and Drug Administration New Hampshire Avenue White Oak, MD

Partners in Progress: Deciding to Participate in Parkinson’s Clinical Research.

A substance used in the diagnosis, treatment, or prevention of a disease or as a component of a medication recognized or defined by the U.S. Food, Drug,

Section I General principle of Pharmacology. Where can you get information about general principle of Pharmacology?  Text books:  Katzung, Basic and.

Clinical Trials.

BY : Dr.Roshini Murugupillai. Pharmacology (Greek : pharmacon – drug ; logos – discourse in) It is the science of drugs It deals with interaction of exogenously.

Tanzania, August 2006 Dr. Barbara Sterzik, BfArM, Bonn 1 Bioequivalence dossier requirements for the prequalification project WHO Training Workshop.

FDA DRUG APPROVAL FDA’s Lengthy Drug Approval Process in Twelve Steps Overview of the FDA Drug Approval Process Drug Developed June 13, 2016 | Emilia Varrone.

Drug Development Process Stages involved in Regulating Drugs

The Stages of a Clinical Trial

Efficacy and Safety of Medicines

Regulatory– Terms & Definitions רגולציה - מונחים והגדרות

Clinical Trials — A Closer Look

Prof. Dr. Basavaraj K. Nanjwade

Clinical Trials Medical Interventions

Pharmaceutical Care Plan

Bozeman Health Clinical Research

The Lifecycle of Pharmaceutical products

9.4 Product Quality Control

Clinical Trials.

Insight into the Pharmaceutical Industry

Drug Design and Drug Discovery

Opening an IND: Investigator Perspective

Objective 2 Biomedical Research Methods

Presentation transcript:

CHEE DRUG PRODUCT DEVELOPMENT u Drug ä agent intended for use in the diagnosis, mitigation, treatment, cure, or prevention of disease in man or animals u New Drug ä defined in section C.0 1A.001(2) of Food and Drug Regulations (HPFB) ä any agent that has not been generally recognized as safe and effective under the conditions recommended

CHEE NEW DRUG u doesn’t have to be a new chemical entity ä formulated differently / new dosage form ä manufactured differently ä combination of 2 or more drugs ä new use for an old drug ä new dosage schedule ä new route of administration

CHEE GOAL DRUG u desired features ä produce desired effect ä administered by desirable route ä minimum dosing and dosing frequency ä optimal onset and duration of activity ä efficient and complete elimination ä easily produced at low cost ä pharmaceutically elegant ä physically and chemically stable

CHEE PRECLINICAL STUDIES u chemical and physical properties u biological properties ä pharmacology ä ADME ä toxicology u Preformulation ä dosage form needs to be sterilizable, prepared in a reproducible fashion, stable, free of impurities

CHEE IND SUBMISSION u Investigational New Drug u required before testing in humans u in Canada, filed with Health Products and Food Branch ä 60 day waiting period u in USA, filed with Food and Drug Administration ä 30 day waiting period

CHEE IND Contents u manufacturer/sponsor name u proprietary name and chemical name of drug u dosage form (route of administration, ingredients, manufacture procedure, packaging, purity, labelling) u data from preclinical animal trials u relationship between preclinical and clinical trials u protocol of clinical trials u names and credentials of all persons involved in all trials u locations of laboratories used u info an any other clinical trials done in other countries

CHEE CLINICAL TRIALS PHASE 1 ä concerned with tolerability and safety of the drug ä generally involves carefully chosen healthy volunteers ä initial dose is quite low, if well tolerated, progressively larger doses given until evidence of drug action observed ä determine the metabolism and pharmacological action of drug in humans

CHEE CLINICAL TRIALS PHASE 2 ä purpose is to determine efficacy of drug (dosage) and to detect side effects not noted in healthy volunteers ä patients suffering from disease are treated in limited numbers (up to several hundred) under close observation

CHEE CLINICAL TRIALS PHASE 3 ä deals with safety and efficacy of drug ä several hundred to a thousand patients ä private practitioners of varying background and experience brought in by the more experienced clinicians ä practitioners report to principal investigator who relays the info and his evaluation to HPFB or FDA

CHEE PHASE SUMMARY

CHEE NEW DRUG SUBMISSION u NDS in Canada, ND Application in US u contents ä all the preclinical and clinical data »includes pharmacokinetics and bioavailability, discussion of risk and benefits, complete proposed product labeling u HPFB and FDA rule on acceptability (2-4 years)

CHEE POST-MARKETING u systematic and comprehensive monitoring of the patterns of use and beneficial or harmful effects of drug as used in medical practice and by the consumer u PHASE 4